SBC / revenue moved 2090 bp higher
SBC / revenue changed +2090 basis points from the comparable as-filed period.
92.19%→113.09%2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →AI financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Capital expenditure decreased 98.9%
Capital expenditure changed -98.9% from the comparable as-filed period.
$760,000→$8,0002 prior comparisons
Free-cash-flow proxy changed across a sign change
Free-cash-flow proxy changed +106.0% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
-$34.3M→$2.1M2 prior comparisons
Operating cash flow changed across a sign change
Operating cash flow changed +106.2% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
-$33.5M→$2.1M2 prior comparisons
Receivables / revenue moved 1841 bp higher
Receivables / revenue changed +1841 basis points from the comparable as-filed period.
162.15%→180.56%2 prior comparisons
Working capital / assets moved 263 bp lower
Working capital / assets changed -263 basis points from the comparable as-filed period.
76.37%→73.74%3 prior comparisons
Trade receivables decreased 17.0%
Trade receivables changed -17.0% from the comparable as-filed period.
$113.9M→$94.6M3 prior comparisons
Stockholders' equity decreased 13.0%
Stockholders' equity changed -13.0% from the comparable as-filed period.
$798.8M→$694.9M2 prior comparisons
Working capital decreased 12.8%
Working capital changed -12.8% from the comparable as-filed period.
$739.8M→$645.0M3 prior comparisons
Free-cash-flow margin moved 5275 bp higher
Free-cash-flow margin changed +5275 basis points from the comparable as-filed period.
-48.81%→3.94%2 prior comparisons
Operating cash-flow margin moved 5169 bp higher
Operating cash-flow margin changed +5169 basis points from the comparable as-filed period.
-47.73%→3.96%2 prior comparisons
R&D / revenue moved 314 bp lower
R&D / revenue changed -314 basis points from the comparable as-filed period.
92.02%→88.88%2 prior comparisons
Capex / revenue moved 107 bp lower
Capex / revenue changed -107 basis points from the comparable as-filed period.
1.08%→0.02%2 prior comparisons
Stock-based compensation decreased 8.6%
Stock-based compensation changed -8.6% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$64.8M→$59.2M2 prior comparisons
Total assets decreased 9.7%
Total assets changed -9.7% from the comparable as-filed period.
$968.7M→$874.8M3 prior comparisons
Current assets decreased 9.5%
Current assets changed -9.5% from the comparable as-filed period.
$851.1M→$770.2M3 prior comparisons
Current ratio decreased 19.5%
Current ratio changed -19.5% from the comparable as-filed period.
7.65→6.163 prior comparisons
Current liabilities increased 12.4%
Current liabilities changed +12.4% from the comparable as-filed period.
$111.3M→$125.1M3 prior comparisons
SBC / revenue moved 7908 bp higher
SBC / revenue changed +7908 basis points from the comparable as-filed period.
63.42%→142.51%0 prior comparisons
Current liabilities decreased 13.8%
Current liabilities changed -13.8% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$138.0M→$118.9M2 prior comparisons
Working capital decreased 16.3%
Working capital changed -16.3% from the comparable as-filed period.
$792.9M→$663.8M2 prior comparisons
Current assets decreased 15.9%
Current assets changed -15.9% from the comparable as-filed period.
$930.9M→$782.7M2 prior comparisons
Total assets decreased 15.1%
Total assets changed -15.1% from the comparable as-filed period.
$1.1B→$895.8M2 prior comparisons
Stock-based compensation increased 21.1%
Stock-based compensation changed +21.1% from the comparable as-filed period.
$62.7M→$75.9M0 prior comparisons
R&D / revenue moved 5036 bp higher
R&D / revenue changed +5036 basis points from the comparable as-filed period.
60.09%→110.44%0 prior comparisons
Free-cash-flow margin moved 8285 bp lower
Free-cash-flow margin changed -8285 basis points from the comparable as-filed period.
-22.66%→-105.51%0 prior comparisons
Operating cash-flow margin moved 8240 bp lower
Operating cash-flow margin changed -8240 basis points from the comparable as-filed period.
-22.29%→-104.69%0 prior comparisons
Receivables / revenue moved 4943 bp higher
Receivables / revenue changed +4943 basis points from the comparable as-filed period.
182.58%→232.01%0 prior comparisons
Capital expenditure increased 21.3%
Capital expenditure changed +21.3% from the comparable as-filed period.
$362,000→$439,0000 prior comparisons
Capex / revenue moved 46 bp higher
Capex / revenue changed +46 basis points from the comparable as-filed period.
0.37%→0.82%0 prior comparisons
Working capital / assets moved 104 bp lower
Working capital / assets changed -104 basis points from the comparable as-filed period.
75.14%→74.10%2 prior comparisons
Research & development decreased 0.9%
Research & development changed -0.9% from the comparable as-filed period.
$59.4M→$58.8M0 prior comparisons
Current ratio decreased 2.4%
Current ratio changed -2.4% from the comparable as-filed period.
6.74→6.582 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.